Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: First-line treatment with afatinib and other EGFR TKIs
Brückl, Wolfgang, Tufman, Amanda, Huber, Rudolf MariaLanguage:
english
Journal:
Expert Review of Anticancer Therapy
DOI:
10.1080/14737140.2017.1266265
Date:
November, 2016
File:
PDF, 806 KB
english, 2016